VALUE OF PLASMA NH2-TERMINAL FRAGMENT OF PRO-OPIOMELANOCORTIN IN MARKING HUMAN-LUNG CANCER IN VARIOUS CLINICAL SETTINGS

被引：0
|
作者：
GILBERT, F [1 ]
CHAN, JSD [1 ]
BENJANNET, S [1 ]
SEIDAH, NG [1 ]
NADEAU, P [1 ]
DURANCEAU, A [1 ]
LAFONTAINE, E [1 ]
BEAULIEU, R [1 ]
CHRETIEN, M [1 ]
机构：
[1] UNIV MONTREAL,CLIN RES INST MONTREAL,BIOCHEM & MOLEC NEUROENDOCRINOL LAB,110 PINE AVE W,MONTREAL H2W 1R7,QUEBEC,CANADA
来源：
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE | 1989年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：285 / 291
页数：7
相关论文
共 11 条
  • [1] URINARY LEVELS OF IMMUNOREACTIVE NH2-TERMINAL OF PRO-OPIOMELANOCORTIN IN PATIENTS WITH MALIGNANT PULMONARY-DISEASE
    GASPAR, L
    GILBERT, F
    CHAN, JSD
    SEIDAH, NG
    CHRETIEN, M
    CLINICAL AND INVESTIGATIVE MEDICINE, 1989, 12 (04): : 241 - 246
  • [2] THE ROLE OF THE NH2-TERMINAL PORTION OF PROOPIOMELANOCORTIN AS A BIOMARKER FOR HUMAN-LUNG CANCER
    GILBERT, F
    WALOP, W
    CHAN, JSD
    BENJANNET, S
    SEIDAH, NG
    SPITZER, WO
    CHRETIEN, M
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (05): : 372 - 376
  • [3] PRIMARY STRUCTURE OF THE MAJOR HUMAN PITUITARY PRO-OPIOMELANOCORTIN NH2-TERMINAL GLYCOPEPTIDE - EVIDENCE FOR AN ALDOSTERONE-STIMULATING ACTIVITY
    SEIDAH, NG
    ROCHEMONT, J
    HAMELIN, J
    LIS, M
    CHRETIEN, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1981, 256 (15) : 7977 - 7984
  • [4] HUMAN NH2 TERMINAL OF PRO-OPIOMELANOCORTIN AS A POTENTIAL MARKER FOR PULMONARY-CARCINOMA
    CHAN, JSD
    SEIDAH, NG
    CHRETIEN, M
    CANCER RESEARCH, 1983, 43 (07) : 3066 - 3069
  • [5] SIMULTANEOUS MEASUREMENT OF ALPHA-HUMAN ATRIAL NATRIURETIC FACTOR (HANF) AND NH2-TERMINAL FRAGMENT OF PRO-HANF IN ESSENTIAL-HYPERTENSION
    MATSUBARA, H
    MORI, Y
    TAKASHIMA, H
    INADA, M
    AMERICAN HEART JOURNAL, 1989, 118 (03) : 494 - 499
  • [6] Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue sarcoma cells: Identification as an NH2-terminal fragment of human fibronectin
    Hu, M
    Pollock, RE
    Nicolson, GL
    CANCER RESEARCH, 1997, 57 (16) : 3577 - 3584
  • [7] Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells
    Teraishi, F
    Zhang, LD
    Guo, W
    Dong, FQ
    Davis, JJ
    Lin, AN
    Fang, BL
    FEBS LETTERS, 2005, 579 (29): : 6681 - 6687
  • [8] Activation of c-Jun NH2-terminal kinase (JNK) and induction of cytotoxic effect in human lung cancer cells by the small compound oncrasin-60 (NSC-743380)
    Wei, Xiaoli
    Guo, Wei
    Wu, Shuhong
    Wang, Li
    Lu, Yiling
    Liu, Jinsong
    Fang, Bingliang
    CANCER RESEARCH, 2009, 69
  • [9] Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer
    Zhang, Xiuqin
    Qin, Yan
    Chen, Xu
    Xiong, Mengrui
    Shu, Song
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [10] A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation
    Jina, Hyeon-Ok
    Seo, Sung-Keum
    Woo, Sang-Hyeok
    Lee, Hyung-Chahn
    Kim, Eun-Sung
    Yoo, Doo-Hyun
    Lee, Su-Jae
    An, Sungkwan
    Choe, Tae-Boo
    Kim, Jong-Il
    Hong, Seok-Il
    Rhee, Chang-Hun
    Park, In-Chul
    LUNG CANCER, 2008, 61 (03) : 317 - 327
12